NICE change could be 'good news' for skin cancer patients
A watchdog U-turn could allow thousands of patients with the deadliest form of skin cancer to receive a pioneering drug that helps the immune system destroy tumours.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units